Checkpoint inhibitors in advanced melanoma: effect on the field of immunotherapy
Author:
Affiliation:
1. Department of Renal & Melanoma, Royal Marsden Hospital, London, UK
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14737140.2017.1341315
Reference50 articles.
1. Bacteria as tumor therapeutics?
2. Cancer immunotherapy: The past, the present and the future
3. CTLA-4 blockade and the renaissance of cancer immunotherapy
4. Enhancement of Antitumor Immunity by CTLA-4 Blockade
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunological Profiles in Mucosal Melanoma with Distinct Prognosis;2024
2. Nanodelivery systems for cutaneous melanoma treatment;European Journal of Pharmaceutics and Biopharmaceutics;2023-03
3. Targeting immune checkpoint pathways in melanoma: triumphs and challenges;Future Drug Discovery;2023-03
4. An immune cell infiltration landscape classification to predict prognosis and immunotherapy effect in oral squamous cell carcinoma;Computer Methods in Biomechanics and Biomedical Engineering;2023-02-16
5. Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma;Acta Dermato-Venereologica;2022-02-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3